Status of secondary prevention in patients undergoing coronary revascularization

Research output: Contribution to journalArticle

Abstract

Cardiologists, primary care physicians, and nurse practitioners play pivotal roles in the secondary prevention of CAD. All patients hospitalized for the treatment of CAD should undergo a comprehensive screening for cardiovascular risk factors and lifestyle behaviors, as well as an evaluation of the need for drug treatment with lipid-lowering agents, angiotensin-converting inhibitors, β blockers, and aspirin. Implementing quality assurance interventions, such as starting lipid-lowering therapy or other pharmacologic therapy before discharge, may improve subsequent management and assist managed care organizations in meeting performance measures mandated by the Health Plan Employer and Data Information Set. The establishment of systematic treatment plans for the management of risk factors after hospitalization for a coronary event or procedure also seems essential if optimal outcomes are to be achieved.

Original languageEnglish (US)
Pages (from-to)1203-1206
Number of pages4
JournalAmerican Journal of Cardiology
Volume87
Issue number10
DOIs
StatePublished - May 15 2001

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Status of secondary prevention in patients undergoing coronary revascularization'. Together they form a unique fingerprint.

  • Cite this